Jason S. Knight/X
Jul 31, 2025, 16:43
Jason S Knight: Antiphospholipid Syndrome Review
Jason S Knight, Professor at University of Michigan Medical School, shared a post on X:
“ICYMI, our review article about antiphospholipid syndrome in ACR Journals is now nicely formatted (and remains free)
Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities․”
Title: Antiphospholipid Syndrome: An Antibody-Mediated Disease With Emerging Therapeutic Opportunities
Authors: Thalia G. Newman, Jason S. Knight
Read the full article here.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin